Calvin B. Van Kwawegen

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Journal: Blood advances
Published: October 15, 2025

Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Journal: Blood
Published: December 11, 2024

Sexuality and bleeding in von Willebrand disease.

Sexuality and bleeding in von Willebrand disease.

Journal: Research and practice in thrombosis and haemostasis
Published: November 18, 2024

Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies.

Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies.

Journal: Research and practice in thrombosis and haemostasis
Published: August 07, 2024

The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells.

The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells.

Journal: Journal of thrombosis and haemostasis : JTH
Published: July 09, 2024

Patient-reported data on the severity of Von Willebrand disease.

Patient-reported data on the severity of Von Willebrand disease.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 20, 2024

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.

Journal: Journal of thrombosis and haemostasis : JTH
Published: March 21, 2024

Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders.

Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders.

Journal: Research and practice in thrombosis and haemostasis
Published: March 01, 2024

Variant mapping using mass spectrometry-based proteotyping as a diagnostic tool in von Willebrand disease.

Variant mapping using mass spectrometry-based proteotyping as a diagnostic tool in von Willebrand disease.

Journal: Journal of thrombosis and haemostasis : JTH
Published: January 17, 2024

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.

Journal: Blood
Published: September 05, 2023

Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients.

Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients.

Journal: Journal of thrombosis and haemostasis : JTH
Published: October 19, 2022

Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.

Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 13, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026